Selling a Dental Practice or DSO: What Buyers Evaluate and How to Maximize Value

How DSOs structure dental acquisitions and why the legal framework matters

For adjacent context, compare this with Selling a Precision Machining or Metal Fabrication Business: What Buyers Evaluate and Selling an Electrical or Plumbing Contractor: M&A Issues Unique to Licensed Trades; the strongest operators connect these topics instead of treating them as separate workstreams.

Most states prohibit corporations from owning dental practices directly, the corporate practice of dentistry (CPD) doctrine requires a licensed dentist to own and control the clinical entity. DSOs have solved this through a split structure: the dentist retains ownership of the professional corporation (PC) or professional limited liability company (PLLC) that holds the dental license and employs clinical staff, while the DSO acquires the management services organization (MSO), the non-clinical assets, equipment, leases, patient records, and the management services agreement (MSA) that governs the relationship between the DSO and the clinical entity.

The practical implication for selling dentists: the purchase price is paid for the MSO assets and the MSA economic rights, not for the clinical practice directly. The selling dentist typically receives the purchase price at closing in exchange for signing the MSA and, in most DSO transactions, a transition employment agreement committing them to practice for 2–5 years post-close. The <a href="/insights/earnouts-ma-why-founders-dont-get-paid" class="subtle-link">earnout</a>, if any, is tied to clinical production metrics during the transition period. Sellers who do not understand this structure before negotiating deal terms routinely miscalculate their net proceeds and total compensation.

Valuation drivers: what DSOs price and what they discount

DSO valuation of dental practices follows a modified EBITDA model that adjusts for owner compensation (dentists frequently under-pay or over-pay themselves relative to market), facility costs (some practices own their building, others lease), and working capital (dental working capital is relatively low due to upfront payment collection models). The adjusted EBITDA is then multiplied by a range that reflects the practice's specific quality attributes.

The multiple range for dental practices in 2024–2026 has compressed slightly from the the low-rate peak peak but remains elevated relative to pre-COVID norms. Single practices trade at 4–6x adjusted EBITDA; multi-location groups with documented systems and distributed production at 6–9x; larger DSOs with 10+ locations at 8–12x. The step-up from single practice to group is real and significant, a dentist who consolidates even two or three practices before a sale can access a meaningfully higher multiple tier.

Selected precedent dental and DSO transactions, 2022-2026

Dental precedent comps need to be sorted by scale. A take-private of the largest Canadian DSO is not a direct comp for a single-location practice, but it is a useful market marker for how large, multi-site dental platforms are valued by institutional buyers.

Source basis: Dentalcorp/GTCR public transaction announcement; Dentalcorp 2025 reporting commentary; Scope Research and public DSO transaction reporting. Platform multiples should be used as context, not as a direct single-practice valuation claim.

What moves the multiple

The precedent comps are useful context, but buyers do not pay the same multiple for every business in a sector. They adjust valuation based on evidence that the business can sustain earnings, transfer customer relationships, and keep operating without the founder carrying the system personally.

The practical seller objective is not to argue that the company deserves the highest public comp. It is to prove which risks do not apply, which risks have already been fixed, and which operating strengths justify the buyer moving toward the higher end of the relevant range.

Provider concentration: the key-man problem in dental practice M&A

The single largest risk factor in dental practice M&A is also the most structurally common: a practice where one dentist generates the majority of clinical production is a practice whose revenue walks out the door if that dentist reduces hours, departs, or does not transition patients effectively. DSO buyers understand this and price it explicitly, a practice where the founding dentist produces 70% of collections will face a discount, a longer transition employment requirement, and earnout provisions tied specifically to the founding dentist's continued production.

The framework buyers use is straightforward: they want to know, if the selling dentist reduces their clinical chair time by 50% over the first 24 months post-close (which is common in DSO transitions), what happens to the practice's revenue? A practice with two associate dentists and a robust patient panel distributed across providers can absorb a founding dentist's partial exit. A practice where every high-value procedure flows through the founding dentist cannot.

Compliance, billing, and regulatory readiness before a DSO process

Dental practice M&A diligence includes a layer of regulatory and compliance review that most founders underestimate. DSO buyers with platform compliance programs conduct formal billing audits, credentialing reviews, HIPAA compliance checks, and infection control documentation reviews as part of standard diligence. Practices that have not been through an external compliance review will encounter these findings for the first time during diligence, with a buyer holding price reduction leverage.

The highest-risk areas in dental compliance diligence are billing: upcoding (billing a higher complexity code than the procedure performed), bundling violations (billing separately for procedures that should be bundled), and Medicaid billing practices where documentation requirements are most stringent. A billing audit in diligence that identifies even $50–75K of patterns that could be characterized as upcoding generates a purchase price adjustment many times the size of the finding, due to False Claims Act exposure.

One area DSO buyers have become increasingly focused on is fee-splitting compliance, arrangements where a practice pays referral fees, marketing fees, or other payments that could be characterized as compensation for patient referrals under state anti-kickback statutes. Any arrangement with a referral source (orthodontist, oral surgeon, primary care physician) that involves payment should be reviewed by healthcare counsel before the sale process.

Preparing a dental practice for sale: the 18-month roadmap

The practices that achieve premium DSO valuations are not the ones that clean up their financials six months before a process, they are the ones that have been running with DSO-ready infrastructure for 18–24 months before a sale. The specific work required depends on the current state of the practice, but the roadmap is consistent.

One commonly overlooked preparation step: patient communication strategy. DSO buyers want to know how the practice plans to communicate the ownership change to patients, and what the expected attrition rate is. Practices that have a clear, tested patient communication plan, including a letter from the founding dentist, a warm introduction to the DSO's brand and approach, and a patient retention protocol, demonstrate operational maturity that buyers value. Practices that have not thought through patient communication are signaling that patient attrition risk is unmanaged.